Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-12-06 Purchase | 2021-12-07 4:13 pm | Xenon Pharmaceuticals Inc. | XENE | Von Seggern Christopher Chief Commercial Officer | 4,000 | $24.4 | $97,600 | 4,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-11 Option Award | 2024-03-12 6:42 pm | N/A 2034-03-10 | Xenon Pharmaceuticals Inc. | XENE | Von Seggern Christopher Chief Commercial Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2023-03-10 Option Award | 2023-03-14 4:47 pm | N/A 2033-03-09 | Xenon Pharmaceuticals Inc. | XENE | Von Seggern Christopher Chief Commercial Officer | 90,000 | $0 | 90,000 (Direct) | View |
| 2022-03-10 Option Award | 2022-03-14 4:24 pm | N/A 2032-03-09 | Xenon Pharmaceuticals Inc. | XENE | Von Seggern Christopher Chief Commercial Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2021-03-12 Option Award | 2021-03-15 4:45 pm | N/A 2031-03-11 | Xenon Pharmaceuticals Inc. | XENE | Von Seggern Christopher Chief Commercial Officer | 60,000 | $0 | 60,000 (Direct) | View |
| 2020-08-17 Option Award | 2020-08-17 6:38 pm | N/A 2030-08-16 | Xenon Pharmaceuticals Inc. | XENE | Von Seggern Christopher Chief Commercial Officer | 100,000 | $0 | 100,000 (Direct) | View |
Ownership | 2020-08-17 4:54 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | Von Seggern Christopher Chief Commercial Officer | 0 | $0 | 0 (Direct) | View |